Pharmacy & Distribution Market Research Reports & Industry Analysis
The U.S. two-class system is divided into prescription and nonprescription, or over-the-counter (OTC), medicines. The advantage is that OTC medicines are conveniently sold in a number of retail outlets so that medicines are available when consumers need them. This emphasis on consumer empowerment directly serves two of the most fundamental demands of any workable health care system -- access and affordability.
In recent years, a few of the world’s pharmacy-only national systems have recognized the growing need for greater access to safe and effective medications. Japan, the Netherlands, Denmark, the United Kingdom, Italy, and Argentina all have been part of this trend toward granting consumers increased access to medicines in more outlets.
The drug distribution system in the U.S. is highly regulated by the U.S. Food and Drug Administration (FDA) to ensure only those medications that have a wide enough safety margin and that can be safely and effectively used without the help of a health care professional are available without a prescription.
The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
Pharmacy & Distribution Industry Research & Market Reports
-
Emergency Department Information Systems
... 2030, growing at a CAGR of 11.9% over the analysis period 2024-2030. Enterprise Solutions, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.1 Billion by the ... Read More
-
Pharmacy Management Systems
... at a CAGR of 11.5% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$15.5 Billion by the end of ... Read More
-
High Volume Dispensing Systems
... 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Systems / Cabinets Component, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.6 Billion ... Read More
-
Pharmacy Inventory Management Software Solutions and Cabinets
... expected to reach US$11.4 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Decentralized Systems, one of the segments analyzed in the report, is expected to record a 10.2% CAGR ... Read More
-
Compounding Pharmacy
... CAGR of 4.5% over the analysis period 2024-2030. Oral Products, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
e-Prescription Systems
... CAGR of 16.7% over the analysis period 2024-2030. e-Prescription Solutions, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$3.2 Billion by the end of the analysis ... Read More
-
E-Prescribing Global Market Report 2025
... strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the most comprehensive ... Read More
-
E-Pharmacy Global Market Report 2025
... strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the most comprehensive ... Read More
-
Global Compounding Pharmacy Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033
... Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc. Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; ... Read More
-
Online Vitamin & Supplement Sales in the US - Industry Market Research Report
... boost sales, as older consumers tend to spend more on vitamins and supplements than younger demographics. The COVID-19 pandemic resulted in sales of immune system supporting vitamins and supplements surging, as consumers sought to increase ... Read More
-
U.S. E-Prescribing Market - Focused Insights 2025-2030
... announced that it is integrating e-prescribing and medication management solutions from health technology pioneer DrFirst into its CDS system. In January 2022, Oracle announced its acquisition of Cerner Corporation, a leading supplier of health information ... Read More
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2025-2033
... global generic drugs market size reached USD 389.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 674.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.66% during 2025-2033. The ... Read More
-
Online Pharmaceutical Sales in Australia - Industry Market Research Report
... either of these models. Pure-play online pharmacies cannot offer the value-added services (like health advice) that their brick-and-mortar counterparts provide, and they cannot compete on price against the heavy discounters. Regulatory controls governing prescription pharmaceutical ... Read More
-
2025 Global: E-Prescribing Software Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
... the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will ... Read More
-
Europe Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
... to 2031. Upsurge in Geriatric Population Drives Europe Dry Eye Products Market Dry eye syndrome is a common eye disorder affecting a substantial share of the population, especially those older than 50. Middle-aged and older ... Read More
-
Asia Pacific Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
... 2023 to 2031. Increasing Initiatives for Eye Care Awareness Boost Asia Pacific Dry Eye Products Market In recent years, various initiatives have been taken to create awareness and educate people regarding eye diseases, prompting patients ... Read More
-
Middle East & Africa Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
... 2.1% from 2023 to 2031. Ongoing Research and Growing Pipeline for Dry Eye Products Bolster Middle East & Africa Dry Eye Products Market The dry eye condition is expected to be seen in the majority ... Read More
-
North America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
... 2023 to 2031. Rising Prevalence of Dry Eye Fuels North America Dry Eye Products Market Dry eye disease (DED) ranks third among the most common reasons for visits to an ophthalmology clinic after refractive errors ... Read More
-
South & Central America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
... 2.7% from 2023 to 2031. Increasing Initiatives for Eye Care Awareness Fuel South & Central America Dry Eye Products Market In recent years, various initiatives have been taken to create awareness and educate people regarding ... Read More
-
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2025-2033
... epilepsy drugs market size reached USD 2.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.87% during 2025-2033. The increasing ... Read More
-
Huntington's Disease Treatment Market Report by Type (Symptomatic Treatment, Disease-modifying Therapies), Drug Type (Approved Drugs, Off-label Drugs), Age (Below 50 Years, Above 50 Years), Distribution Channel (Drug Stores and Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033
... End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033 The global Huntington's disease treatment market size reached USD 578.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,443 ... Read More
-
Global Cold Chain Logistics Market for Pharmaceuticals Industry 2025-2029
... period. The report on the cold chain logistics market for pharmaceuticals industry provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Registered Online Pharmacies (UK) - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Registered Online Pharmacies (UK) report will tell you the ... Read More
Research Assistance
